Limited Efficacy of Lenvatinib in Heavily Pretreated Anaplastic Thyroid Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Endocrine-related cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Limited Efficacy of Lenvatinib in Heavily Pretreated Anaplastic Thyroid Cancer: A French Overview
Endocr. Relat. Cancer 2020 Oct 01;[EPub Ahead of Print], C Sparano, Y Godbert, M Attard, C Do Cao, S Zerdoud, N Roudaut, C Joly, A Berdelou, J Hadoux, L Lamartina, M Schlumberger, S LeboulleuxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.